Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adisco
Cambridge, Massachusetts, USA
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Adisco is an early-stage biotechnology company pioneering in vivo cellular reprogramming to treat chronic and degenerative diseases. Founded by Moderna co-founder Derek Rossi, the company leverages its proprietary Antibody-Directed In Situ Cellular reprogramming (ADISCO) platform to deliver therapeutic payloads, such as mRNA, directly to specific cells within the body. This technology aims to reprogram existing cells into functional, healthy cell types, potentially providing regenerative cures for conditions like diabetes and heart disease without the need for complex ex vivo cell manufacturing. Adisco represents a significant shift toward scalable, off-the-shelf regenerative medicine.
- Therapeutic areas
- CardiovascularNeurologyEndocrinology
- Modalities
- mRNA-based drugsMonoclonal antibodyCell therapyGene therapyRecombinant proteinLipid nanoparticle delivery therapy
- Industry
- Biotech
Beyond the preview
Go deeper on Adisco.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adisco.